Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Mar 27, 2026
Why Is CoreWeave (CRWV) Stock Down -7% Today?

Why Is CoreWeave (CRWV) Stock Down -7% Today?

Key Takeaways

  • CRWV shares are down approximately 7% in Friday's session, extending a multi-session sell-off to new recent lows
  • The primary overhang remains the Q4 2025 earnings report, which included a wider-than-expected net loss and Q1 2026 revenue guidance that significantly missed analyst expectations
  • CoreWeave's announcement of $30–$35 billion in 2026 capital expenditures — more than double the prior year — continues to stoke investor concern about leverage and the timeline to profitability
  • Broader macro headwinds, including oil prices declining to four-year lows, are intensifying risk-off sentiment across high-multiple AI growth stocks
  • Persistent insider selling activity has created a continuing supply overhang on the stock
  • Traders are now focused on Q1 2026 earnings, any updates on contract execution, and near-term financing developments as the next potential turning points

Opening Summary

CoreWeave, Inc. (CRWV) is a specialized cloud infrastructure provider that delivers high-performance, GPU-accelerated computing capacity designed specifically for artificial intelligence workloads. The company counts major AI players such as Microsoft, Meta, and OpenAI among its key customers and went public in March 2025 in what was the largest U.S. technology IPO in years. On Friday, March 27, 2026, shares are trading approximately 7% lower intraday, falling to around $74.82 from the prior session's close of $80.45. The decline marks the second consecutive day of significant losses as investor confidence continues to erode amid earnings concerns, a massive spending ramp, and deteriorating AI sector sentiment.

Earnings Hangover and Weak Q1 Guidance

The most significant structural driver of the ongoing sell-off traces to CoreWeave's Q4 2025 earnings report, released in late February 2026. Revenue of $1.57 billion — up 110% year-over-year — cleared analyst estimates, but the bottom line disappointed sharply. The company posted a net loss of $452 million, well above the $342 million projected by analysts, and a diluted EPS loss of $0.89 versus the consensus estimate of -$0.61. Crucially, Q1 2026 revenue guidance of approximately $1.9–$2.0 billion came in well below analyst expectations in the range of $2.24–$2.29 billion, triggering an initial 18%+ single-session collapse that has set the tone for continued selling pressure in the weeks since.

Aggressive Capex Plans Raise Leverage Fears

CoreWeave's guidance for $30 billion to $35 billion in 2026 capital expenditures — more than doubling the $14.9 billion spent in 2025 and far exceeding analyst estimates of approximately $26.9 billion — has become a persistent headwind that markets have yet to fully digest. The scale of the buildout, targeting expanded AI data center capacity ahead of anticipated demand, raises immediate questions about the company's debt service capacity, cash burn trajectory, and path to positive free cash flow. While management points to a contracted revenue backlog of $66.8 billion as justification for the investment, the gap between current cash outflows and future revenue recognition remains a key concern for institutional investors weighing the risk-reward profile of CRWV.

AI Sector Sentiment and Macro Pressures

Friday's session is unfolding within a broader environment of AI sector caution. Oil prices declining to four-year lows reflect growing anxiety about global economic momentum, which is driving investors to reduce exposure to high-multiple, capital-intensive growth names. CRWV is particularly exposed to this dynamic given its lack of profitability, significant debt load, and elevated valuation relative to near-term earnings power. An ongoing class-action securities fraud lawsuit filed against the company in late 2025 adds an additional layer of legal and reputational risk that has continued to weigh on sentiment throughout the first quarter of 2026.

Insider Selling Overhang

Sustained insider and early-investor selling has also applied consistent downward pressure on CRWV. Over recent months, hundreds of millions of dollars in shares have been offloaded by insiders, including a recent Form 144 filing from Omnadora Capital LLC indicating plans to sell approximately $4.15 million in shares. While the pace of selling in Q1 2026 slowed materially compared to the $2.3 billion in insider transactions seen in Q4 2025, the continued presence of selling activity signals ongoing caution among those closest to the business and suppresses meaningful buying conviction in the near term.

Market Context and Trading Activity

CRWV has now declined approximately 50% from its mid-2025 all-time highs, significantly underperforming the broader AI infrastructure space. Volume during recent sell-off sessions has run well above 30-day averages, suggesting institutional-driven distribution rather than opportunistic light-volume weakness. The stock is trading below its key short-term moving averages, and technical support in the low-$80s range has already been lost. AI infrastructure peers and broader technology indices have shown greater relative resilience, emphasizing the company-specific nature of the pressure on CRWV even as macro sentiment adds an additional sector-wide headwind.

Trending AI Robots

For traders navigating volatile AI stocks like CRWV, Tickeron's Trending AI Robots page offers a curated selection of the platform's best-performing automated trading bots under current market conditions. Tickeron operates hundreds of AI-powered robots covering thousands of tickers across a wide range of strategies, timeframes, risk profiles, and performance metrics — but only those delivering the strongest results in live market conditions earn a place in the Trending section. Whether you are trading high-volatility AI growth names or seeking more stable setups in other sectors, exploring the Trending AI Robots page provides a data-driven, systematic approach to capturing opportunities in fast-moving markets.

What Comes Next for CRWV

The next major catalyst for CRWV will be its Q1 2026 earnings report, expected in May, where analysts will scrutinize whether revenue lands within the guided range of $1.9–$2.0 billion and whether any progress has been made on narrowing losses. Key items to watch include updates on the $66.8 billion contracted backlog conversion pace, any revisions to the full-year capex outlook, and developments around the company's ongoing debt financing arrangements — reportedly backed in part by long-term commitments from Meta. The resolution of the outstanding class-action litigation and any shifts in AI hyperscaler spending commitments from customers such as Microsoft and OpenAI will also be closely watched. Macro developments around AI infrastructure investment sentiment and broader technology valuations will continue to shape the backdrop for CRWV in the weeks ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: CRWV

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CRWV's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for CRWV moved out of overbought territory on August 13, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 instances where the indicator moved out of the overbought zone. In of the 10 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRWV as a result. In of 19 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CRWV moved below its 50-day moving average on August 20, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRWV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRWV broke above its upper Bollinger Band on August 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CRWV entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for CRWV just turned positive on July 31, 2026. Looking at past instances where CRWV's MACD turned positive, the stock continued to rise in of 12 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for CRWV crossed bullishly above the 50-day moving average on August 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where CRWV advanced for three days, in of 79 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.643) is normal, around the industry mean (22.706). P/E Ratio (0.000) is within average values for comparable stocks, (70.701). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.165). CRWV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (6.031) is also within normal values, averaging (111.934).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CRWV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRWV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), MongoDB (NASDAQ:MDB), Twilio (NYSE:TWLO), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 33.88B. The market cap for tickers in the group ranges from 48.8K to 3.59T. MSFT holds the highest valuation in this group at 3.59T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was -1%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 18%. WETO experienced the highest price growth at 216%, while YYAI experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was -11% and the average quarterly volume growth was -60%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 71
Price Growth Rating: 55
SMR Rating: 79
Profit Risk Rating: 91
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
CRWV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ComputerCommunications

Profile
Details
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.